Quick Answer
PALVELLA THERAPEUTICS, INC. reported Total Revenue of $42.81 million for the year ending 2023.
- PALVELLA THERAPEUTICS, INC. showed an increase of +65.3% in Total Revenue from 2022 to 2023.
- This data is from PALVELLA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 29, 2024.
- XBRL data for this metric is available from 2013 to 2023 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $0.00 | Q4 2013: $0.00 | Q1 2014: $1.37 million | Q2 2014: $698.2 thousand | Q3 2014: $18.7 thousand | Q1 2015: $217.6 thousand | Q2 2015: $160.2 thousand | Q3 2015: $414.6 thousand | Q1 2016: $1.25 million | Q2 2016: $1.07 million | Q3 2016: $785.0 thousand | Q1 2017: $1.34 million | Q2 2017: $1.85 million | Q3 2017: $3.93 million | Q1 2018: $4.15 million | Q2 2018: $11.69 million | Q3 2018: $8.35 million | Q1 2019: $8.55 million | Q2 2019: $5.33 million | Q3 2019: $15.13 million | Q1 2020: $13.26 million | Q2 2020: $11.25 million | Q3 2020: $2.94 million | Q1 2021: $15.63 million | Q2 2021: $3.29 million | Q3 2021: $4.06 million | Q1 2022: $10.99 million | Q2 2022: $3.70 million | Q3 2022: $5.37 million | Q1 2023: $1.94 million | Q2 2023: $20.06 million | Q3 2023: $19.52 million | Q1 2024: $53.0 thousand | Q2 2024: $0.00 | Q3 2024: $0.00.
- Historical annual values: Fiscal year 2023: $42.81 million | Fiscal year 2022: $25.90 million | Fiscal year 2021: $31.42 million | Fiscal year 2020: $29.32 million | Fiscal year 2019: $46.28 million | Fiscal year 2018: $29.10 million | Fiscal year 2017: $25.28 million | Fiscal year 2016: $5.83 million | Fiscal year 2015: $2.93 million | Fiscal year 2014: $5.37 million | Fiscal year 2014: $0.00 | Fiscal year 2013: $12.43 million | Fiscal year 2013: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: